QC6352

12 Cited Publications
カスタマーレビュー

Based on 12 publication(s) in Google Scholar

QC6352 is a DHODH and KDM4 inhibitor. The IC50 values of QC6352 for human DHODH, KDM4A, KDM4B, KDM4C, and KDM4D are 0.3 nM, 104 nM, 56 nM, 35 nM, and 104 nM, respectively. QC6352 inhibits JmjC domain Fe (II)/2-ketoglutarate-dependent histone demethylases and blocks DHODH-mediated de novo pyrimidine biosynthesis through ubiquinone binding, reducing H3K9me3/H3K36me3 demethylation and increasing histone methylation marks. QC6352 induces G0/G1 phase arrest, senescence, apoptosis (apoptosis), DNA damage, and interferon/chemokine responses, and reduces stemness markers and BMI1+ cancer stem cells, exhibiting selective antiproliferative/cytotostatic activity against glioblastoma cells with limited effects on normal astrocytes. QC6352 can be used for research on glioblastoma, breast cancer, squamous cell carcinoma, and TP53-mutant acute myeloid leukemia.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

  • 純度 : 99.13%
  • CAS 番号: 1851373-36-8
  • 分子式: C24H25N3O2
  • 分子量:387.47
  • 保管条件:

    4°C, protect from light

    * In solvent : -80°C, 2 years; -20°C, 1 year (protect from light)

  • 生物活性
  • 化学情報
  • 溶剤 & 溶解度
  • プロトコル
  • 純度とドキュメンテーション
  • 参考文献
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

お問い合わせ 在庫あり

Other size
お問い合わせ
Please select quantity
Amount: USD 0.00